Dolby Laboratories (NYSE:DLB – Get Free Report) SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $6,316,276.40. This represents a 6.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Dolby Laboratories Price Performance
Shares of NYSE DLB opened at $49.98 on Thursday. Dolby Laboratories has a fifty-two week low of $48.66 and a fifty-two week high of $77.00. The firm has a market capitalization of $4.73 billion, a P/E ratio of 19.76 and a beta of 0.81. The company’s 50 day simple moving average is $54.46 and its 200 day simple moving average is $60.25.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the previous year, the business earned $1.34 EPS. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts expect that Dolby Laboratories will post 3.21 EPS for the current fiscal year.
Dolby Laboratories Dividend Announcement
Institutional Trading of Dolby Laboratories
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Boothbay Fund Management LLC boosted its position in Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after purchasing an additional 157 shares during the last quarter. Covestor Ltd increased its position in shares of Dolby Laboratories by 6.0% during the 4th quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after purchasing an additional 175 shares during the last quarter. Fifth Third Bancorp raised its stake in shares of Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after purchasing an additional 192 shares in the last quarter. State of Michigan Retirement System raised its stake in shares of Dolby Laboratories by 1.4% during the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after purchasing an additional 200 shares in the last quarter. Finally, Gabelli Funds LLC boosted its holdings in shares of Dolby Laboratories by 0.4% in the 3rd quarter. Gabelli Funds LLC now owns 49,143 shares of the electronics maker’s stock valued at $3,556,000 after buying an additional 202 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.
Analyst Upgrades and Downgrades
DLB has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Thursday, June 11th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Finally, Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Check Out Our Latest Stock Analysis on DLB
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
